Jim Cramer on Gilead Sciences: “I’d Hold On to It”

2 weeks ago 10

Syeda Seirut Javed

Fri, April 17, 2026 astatine 11:14 AM CDT 1 min read

Gilead Sciences, Inc. (NASDAQ:GILD) was among the stocks Jim Cramer reviewed connected Mad Money portion discussing the caller marketplace rotation. During the lightning round, a caller asked for Cramer’s instrumentality connected the stock, and helium replied:

You know, I similar what Daniel O’Day is doing. I ever bump into him astatine the JPMorgan conference. I deliberation he’s a astute guy, and the company’s good. I’d clasp connected to it. They’ve got immoderate bully franchises.

A banal marketplace data. Photo by AlphaTradeZone connected Pexels

Gilead Sciences, Inc. (NASDAQ:GILD) is simply a biopharmaceutical institution that develops treatments for large aesculapian conditions similar HIV, hepatitis, and COVID-19. The institution besides uses precocious compartment therapies for crab treatment, and it maintains respective partnerships to observe caller small-molecule and antibody medicines.

While we admit the imaginable of GILD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article